ANAZAOHEALTH CORPORATION

Lobbying Spend

—

Filings

Firms Hired

Active Period

2003–2015

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2015	—	4	1
2014	—	4	1
2013	—	6	1
2012	—	2	1
2011	—	2	1
2007	—	2	1
2006	—	1	1
2005	—	1	1
2004	—	2	1
2003	—	4	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
ARMORY HILL ADVOCATES (FORMERLY KNOWN AS RAWLSON POLICY GROUP)	—	14
MR. MARK SHARPE	—	10
BUTLER SNOW LLP	—	4

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
SENATE	20
HOUSE OF REPRESENTATIVES	19
Food & Drug Administration (FDA)	8
Health & Human Services, Dept of (HHS)	6
Homeland Security, Dept of (DHS)	3
Centers For Medicare and Medicaid Services (CMS)	1
Drug Enforcement Administration (DEA)	1

Most frequently reported lobbying issues

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 3204113th Congress

Drug Quality and Security Act

Cited source text and reported amounts

Issues regarding proposed legislation impacting Compounding Pharmacy Companies & Organizations, HR 3204. S. 959

Client expense: — · Firm income: $22,000

Matched citations: HR 3204

S. 959113th Congress

Pharmaceutical Quality, Security, and Accountability Act

Cited source text and reported amounts

Issues regarding proposed legislation impacting Compounding Pharmacy Companies & Organizations, HR 3204. S. 959

Client expense: — · Firm income: $22,000

Matched citations: S. 959

ANAZAOHEALTH CORPORATION — Lobbying Disclosure | Poliscope